TITLE

Clinical trial participation poses ethical, practical issues

AUTHOR(S)
Silversides, Ann
PUB. DATE
March 2009
SOURCE
CMAJ: Canadian Medical Association Journal;3/3/2009, Vol. 180 Issue 5, p500
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article reports on the ethical issues involving physicians who recruit patients to participate in clinical trials in Canada. It reveals that ethical concern has emerged concerning the amount of money received by physicians which may result to conflicts of interest as well as challenges the safety and wellbeing of patients. It was found that to address the problem, health care facilities and institutions have developed ethical guidelines on physician's involvement in trials where failure to comply with the standards will subject them to professional misconduct and penalty.
ACCESSION #
36872183

 

Related Articles

  • DRUG TRIALS SHOW BUT NO ONE TELLS. Guest, JIm // Consumer Reports;Oct2004, Vol. 69 Issue 10, p5 

    Discusses the information that consumers may not be getting about the clinical trials for prescription drugs. Assertion that patients, doctors and even the United States Food and Drug Administration do not have access to the results of all clinical trials; Unacceptable aspect of withholding...

  • Clinical trials beyond the darker side? Damle, S. G. // Journal of the Indian Society of Pedodontics & Preventive Dentis;Mar2006, Vol. 24 Issue 1, p6 

    States that India are becoming a global hub for drug trials. Reasons why many drug trials are conducted in the country; View on doctor patient relationship; Importance of transparency in drug trials.

  • The Protection of Patients' Rights in Clinical Trials. Czarkowski, Marek // Science & Engineering Ethics;Jan2006, Vol. 12 Issue 1, p131 

    The Helsinki Declaration is a very important document regarding the protection of patients' rights in clinical trials and one of the fundamental sources of operational principles for every ethics committee. Although they have been updated, the international guidelines for ethics committees...

  • Articulating and Responding to Uncertainties in Clinical Research. Djulbegovic, Benjamin // Journal of Medicine & Philosophy;Mar/Apr2007, Vol. 32 Issue 2, p79 

    This paper introduces taxonomy of clinical uncertaintes and argues that the choice of scientific method should match the underlying level of uncertainty. Clinical trial is one of these methods aiming to resolve clinical uncertainties. Whenever possible these uncertainties should be quantified....

  • Ethical disclosure. Kondro, Wayne // CMAJ: Canadian Medical Association Journal;3/3/2009, Vol. 180 Issue 5, p505 

    The article reports on the ethical disclosure guidelines for physicians and scientists developed by the Association for Medical Ethics in Canada. The guidelines require physicians and scientists to make financial disclosure for trials that exceed $500 every year as well as should avoid financial...

  • When Does Innovative Care Become Clinical Research? Mackintosh, Douglas R.; Molloy, Vernette J. // Applied Clinical Trials;Feb2005, Vol. 14 Issue 2, p59 

    This article examines the overlapping of clinical research by medical care. There are compounds administered to patients, as well as procedures performed on patients that are unapproved, untested, and could in no way be considered the generally accepted standard of care. These therapies are...

  • Polling surgeons. Gross, Michael // Canadian Journal of Surgery;Dec2005, Vol. 48 Issue 6, p433 

    The article addresses the need to obtain and analyze the opinions of surgeons who are members of a subspecialty and often base their treatment efforts upon what they feel rather than on the results of the clinical trials that they may have participated in or read about. The article determines...

  • Uniform guidelines for reporting COI within industry-sponsored clinical trials (ISCT). Hussey, Valerie // Multiple Sclerosis Journal;Oct2015, Vol. 21 Issue 12, p1496 

    The author discusses the importance of removing the reporting of conflict of interest (COI) within industry-sponsored clinical trials (ISCT). The author mentions the benefits of comprehensive, rigorous, and standardized practices to address COI to preserve relationship of patients to the health...

  • Head 'em off at the pass: Be prepared for study objections. Warner, K. C. // Pharmaceutical Representative;Oct2006, Vol. 36 Issue 10, p30 

    The article offers advise on preparing for objections on one's clinical studies which are excellent tools in supporting selling messages and help physicians make informed prescribing choices. Objections indicate that physicians have looked at one's study and have not dismissed it without...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics